Skip to main content
. 2018 Jan 19;13(1):e0191293. doi: 10.1371/journal.pone.0191293

Table 3. Odds of non-beneficial PEG tubes among the different race/sex groups stratified by stroke type.

Variable % PEG Crude OR
(95% CI)
of PEG
Adjusted* OR (95% CI)
of PEG
All Stroke
    White Female 3.8 1 (ref) 1 (ref)
    Minority Female 10.4 2.98 (2.63–3.37) 2.08 (1.81–2.41)
    White Male 6.5 1.76 (1.58–1.97) 1.46 (1.30–1.64)
    Minority Male 11.9 3.45 (3.03–3.91) 2.10 (1.78–2.48)
Ischemic Stroke
    White Female 4.1 1 (ref) 1 (ref)
    Minority Female 11.1 2.96 (2.57–3.41) 2.17 (1.85–2.54)
    White Male 6.8 1.73 (1.53–1.96) 1.43 (1.25–1.63)
    Minority Male 13.0 3.54 (3.04–4.11) 2.32 (1.91–2.81)
Intracerebral hemorrhage
    White Female 2.9 1 (ref) 1 (ref)
    Minority Female 9.0 3.35 (2.59–4.34) 1.91 (1.39–2.62)
    White Male 5.6 2.02 (1.59–2.57) 1.64 (1.23–2.19)
    Minority Male 10.1 3.85 (2.99–4.95) 1.71 (1.22–2.39)

*Model adjusted for age, hospital teaching status, hospital bed size, hospital location, hospital region, and annual volume of stroke cases, discharge quarter, weekend admission status, modified Charlson Comorbidity Index, APR-DRG severity subclass, insurance status, median household income per patient’s ZIP code, hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, peripheral vascular disease, congestive heart failure, atrial fibrillation, valvular disease, anemia, thrombocytopenia, alcohol abuse, drug abuse, chronic kidney disease, pneumonia, urinary tract infection, sepsis, gastrointestinal bleeding, deep vein thrombosis, and pulmonary embolism.